Clinical Trial Detail

NCT ID NCT02302807
Title A Study of MPDL3280A Compared With Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

urethra transitional cell carcinoma

ureter transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

Therapies

Paclitaxel

Vinorelbine

Atezolizumab

Docetaxel

Age Groups: adult

No variant requirements are available.